More than 6 million Americans are living with Alzheimer’s. By 2050, this number is projected to rise to nearly 13 million.

Kal Kalotai and David Cowing joined Michelle Palomera in the 2022 Walk to End Alzheimer’s on Saturday. It was great to see so many people come together to support research into Alzheimer’s. Through mid-November you can support Michelle’s fundraising for the Alzheimer’s association by making a donation here: http://act.alz.org/goto/sullysfootpatrol.

Alzheimer’s is a devastating disease that affects the brain. It causes problems with memory, thinking, and behavior. Over time, it gets worse and can lead to death. There is no cure for Alzheimer’s, but there are treatments that can help manage the symptoms.

Alzheimer’s is the most common form of dementia, accounting for 60-80% of all cases. Dementia is a general term for a decline in mental ability due to disease or injury. Alzheimer’s is not a normal part of aging. It is a progressive, degenerative disease that attacks the brain and affects a person’s ability to function.

@alzassociation @alzheimersmanh #endalz @scituate #fundraising

About Walk to End Alzheimer’s

Held annually in more than 600 communities nationwide, Walk to End Alzheimer’s is the world’s largest event to raise awareness and funds for Alzheimer’s care, support and research.

By joining the Walk to End Alzheimer’s, we can come together to support and fund vital research and care programs that make a real difference in the lives of those affected by this disease. With your help, we can move closer to our ultimate goal: a world without Alzheimer’s.

Learn more about the Annual Walk to End Alzheimer’s at The Alzheimer’s Association

About NovusNorth

NovusNorth is an outcome-oriented experience consultancy that designs and develops digital products and business applications that are front-office and customer-facing. Capabilities include strategy, design, technology, and product management. Building on decades of experience helping firms compete and delight their customers, they’ve created a new way of delivering digital applications that starts with metrics and embeds measurement throughout the process. NovusNorth specializes in designing and delivering easy-to-use solutions for complex industries such as insurance, banking, capital markets, healthcare, and life sciences.

Learn More About NovusNorth

More than 6 million Americans are living with Alzheimer’s. By 2050, this number is projected to rise to nearly 13 million.

Kal Kalotai and David Cowing joined Michelle Palomera in the 2022 Walk to End Alzheimer’s on Saturday. It was great to see so many people come together to support research into Alzheimer’s. Through mid-November you can support Michelle’s fundraising for the Alzheimer’s association by making a donation here: http://act.alz.org/goto/sullysfootpatrol.

Alzheimer’s is a devastating disease that affects the brain. It causes problems with memory, thinking, and behavior. Over time, it gets worse and can lead to death. There is no cure for Alzheimer’s, but there are treatments that can help manage the symptoms.

Alzheimer’s is the most common form of dementia, accounting for 60-80% of all cases. Dementia is a general term for a decline in mental ability due to disease or injury. Alzheimer’s is not a normal part of aging. It is a progressive, degenerative disease that attacks the brain and affects a person’s ability to function.

@alzassociation @alzheimersmanh #endalz @scituate #fundraising

About Walk to End Alzheimer’s

Held annually in more than 600 communities nationwide, Walk to End Alzheimer’s is the world’s largest event to raise awareness and funds for Alzheimer’s care, support and research.

By joining the Walk to End Alzheimer’s, we can come together to support and fund vital research and care programs that make a real difference in the lives of those affected by this disease. With your help, we can move closer to our ultimate goal: a world without Alzheimer’s.

Learn more about the Annual Walk to End Alzheimer’s at The Alzheimer’s Association

About NovusNorth

NovusNorth is an outcome-oriented experience consultancy that designs and develops digital products and business applications that are front-office and customer-facing. Capabilities include strategy, design, technology, and product management. Building on decades of experience helping firms compete and delight their customers, they’ve created a new way of delivering digital applications that starts with metrics and embeds measurement throughout the process. NovusNorth specializes in designing and delivering easy-to-use solutions for complex industries such as insurance, banking, capital markets, healthcare, and life sciences.

Learn More About NovusNorth

Exploring what’s next?

CONTACT US

Exploring what’s next for your organization?

CONTACT US

Hello and thanks for stopping by!

(Now that you know us a little bit better, send us a message and let’s talk about you.)

Send Us A Message Now

Our Capabilities

We’re ready to help you envision and create great digital experiences that achieve your goals.

About Us

Say hello to the team and get a peek into who we are, our culture, and why we’ll make great partners.

Our Latest Insights

  • Product planning and management requires discipline, practical decision making, and flexibility. Learn how product roadmaps are used to achieve success for both short and long term value-added feature releases to customers for a community bank.

    By NovusNorth

  • The NovusNorth team participated in the 2022 Walk to End Alzheimer's in Scituate, MA. More than 6 million people are living with Alzheimer's today and 13 Million will by 2050.

    By NovusNorth

  • Leading Product in an Emerging industry requires insight and flexibility. Learn more from the Product Director at YellowDog, a leader in cloud workload management.

    By NovusNorth